Estadísticas de EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP)

Visitas totales

views
EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP) 0

Visitas totales por mes

views
enero 2024 0
febrero 2024 0
marzo 2024 0
abril 2024 0
mayo 2024 0
junio 2024 0
julio 2024 0

Visitas de archivo

views
EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP).pdf 13